Fatigue in multiple sclerosis - A brief review

Journal of the Neurological Sciences

Volumn 323, Issue 1-2, 2012, Pages 9-15

  Induruwa, Isuru ^a   Constantinescu, Cris S ^a   Gran, Bruno ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Fatigue; Multiple sclerosis; Pathophysiology

Indexed keywords

AMANTADINE; CORTICOTROPIN; CREATININE; GAMMA INTERFERON; GLATIRAMER; HYDROCORTISONE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; METHYLPHENIDATE; MODAFINIL; OREXIN A; PEMOLINE; PLACEBO; PRASTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC EXERCISE; AXONAL INJURY; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN DAMAGE; BRAIN RADIOGRAPHY; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CORPUS CALLOSUM; CORTICOTROPIN BLOOD LEVEL; DAYTIME SOMNOLENCE; DEMOGRAPHY; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EPWORTH SLEEPINESS SCALE; EVOKED MUSCLE RESPONSE; EXERCISE; FATIGUE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDUCED HYPOTHERMIA; MULTIPLE SCLEROSIS; MUSCLE SPASM; NERVE CELL NETWORK; NOCTURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PSYCHOTHERAPY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEX DIFFERENCE; SINGLE DRUG DOSE; SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; TRANSCRANIAL MAGNETIC STIMULATION; UNSPECIFIED SIDE EFFECT;

AMANTADINE; ATROPHY; BENZHYDRYL COMPOUNDS; BRAIN; CLINICAL TRIALS AS TOPIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYTOKINES; DEPRESSION; DIFFUSE AXONAL INJURY; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FATIGUE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; PEMOLINE; PITUITARY-ADRENAL SYSTEM; QUALITY OF LIFE; SINGLE-BLIND METHOD; SLEEP DISORDERS, INTRINSIC;

EID: 84867883963     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.08.007     Document Type: Review

References (98)

1. L. Krupp Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease Mult Scler 12 2006 367 368
2. A. Lerdal, E.G. Celius, L. Krupp, and A.A. Dahl A prospective study of patterns of fatigue in multiple sclerosis Eur J Neurol 14 2007 1338 1343
3. G. Giovannoni Multiple sclerosis related fatigue J Neurol Neurosurg Psychiatry 77 2006 2 3
4. L.B. Krupp The most common complaints: fatigue 2003 Butterworth Heinemann - Elsevier Science Philadelphia
5. R.J. Mills, and C.A. Young A medical definition of fatigue in multiple sclerosis QJM 101 2008 49 60
6. L.B. Krupp, D.J. Serafin, and C. Christodoulou Multiple sclerosis associated fatigue Expert Rev Neurother 10 2010 1437 1447
7. L. Leocani, B. Colombo, and G. Comi Physiopathology of fatigue in multiple sclerosis Neurol Sci 29 Suppl. 2 2008 S241 S243
8. Y. Barak, and A. Achiron Cognitive fatigue in multiple sclerosis: findings from a two-wave screening project J Neurol Sci 245 2006 73 76
9. E. Patrick, P.E. Christodolou, and L.B. Krupp Longitudinal correlates of fatigue in multiple sclerosis Mult Scler 15 2009 258 261
10. M.E. Morris, C. Cantwell, L. Vowels, and K. Dodd Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis J Neurol Neurosurg Psychiatry 72 2002 361 365
11. G. Comi, L. Leocani, P. Rossi, and B. Colombo Physiopathology and treatment of fatigue in multiple sclerosis J Neurol 248 2001 174 179
12. V.M. Leavitt, J.F. Sumowski, N. Chiaravalloti, and J. Deluca Warmer outdoor temperature is associated with worse cognitive status in multiple sclerosis Neurology 78 2012 964 968
13. Bol Y, Smolders J, Duits A, Lange IM, Romberg-Camps M, Hupperts R. Fatigue and heat sensitivity in patients with multiple sclerosis. Acta Neurol Scand in press Mar 8, http://dx.doi.org/10.1111/j.1600-0404.2012.01660.x. [PMID: 22404677].
14. R. Bakshi Fatigue associated with multiple sclerosis: diagnosis, impact and management Mult Scler 9 2003 219 227
15. V. Janardhan, and R. Bakshi Quality of life in patients with multiple sclerosis: the impact of fatigue and depression J Neurol Sci 205 2002 51 58
16. K.J. Aronson Quality of life amongst persons with multiple sclerosis and their caregivers Neurology 48 1997 74 81
17. M. Olsson, J. Lexell, and S. Söderberg The meaning of fatigue for women with multiple sclerosis J Adv Nurs 49 2005 7 15
18. P. Flachenecker, T. Kumpfel, B. Kallmann, M. Gottschalk, O. Grauer, and P. Rieckmann Fatigue in multiple sclerosis; a comparison of different rating scales and correlation to clinical parameters Mult Scler 8 2002 523 526
19. J. Iriarte, G. Katsamakis, and P. de Castro The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis Mult Scler 5 1999 10 16
20. D. Kos, G. Nagels, M.B. D'Hooghe, M. Duportail, and E. Kerckhofs A rapid screening tool for fatigue impact in multiple sclerosis BMC Neurol 17 2006 1
21. R.J. Mills, C.A. Young, J.F. Pallant, and A. Tennant Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS) Health Qual Life Outcomes 12 2010 8 22
22. M. Mollaoglu, and E. Ustun Fatigue in multiple sclerosis patients J Clin Nurs 18 2009 1231 1238
23. N. Téllez, J. Río, M. Tintoré, C. Nos, I. Galán, and X. Montalban Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler 11 2005 198 202
24. J.H. Vercoulen, O.R. Hommes, C.M. Swanink, P.J. Jongen, and J.F. Fennis The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects Arch Clin Neurol 53 1996 642 649
25. P.O. Valko, C.L Bassetti, K.E Bloch, U. Held, and C.R. Baumann Validation of the fatigue severity scale in a Swiss cohort Sleep 31 2009 1601 1607
26. C. Heesen, L. Nawrath, C. Reich, N. Bauer, K.H. Schulz, and S.M. Gold Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 77 2006 34 39
27. P. Flachenecker, I. Bihler, F. Weber, M. Gottschalk, K.V. Toyka, and P. Rieckmann Cytokine mRNA expression in patients with multiple sclerosis and fatigue Mult Scler 10 2004 165 169
28. P. Hautecoeur, G. Forzy, P. Gallois, V. Demirbilek, and O. Feugas Variations of IL2, IL6, TNF alpha plasmatic levels in relapsing remitting multiple sclerosis Acta Neurol Belg 97 1997 240 243
29. G. Giovannoni, A.J. Thompson, D.H. Miller, and E.J. Thompson Fatigue is not associated with raised inflammatory markers in multiple sclerosis Neurology 57 2001 676 681
30. R. Bakshi, R.S. Miletich, K. Henschel, Z.A. Shaikh, V. Janardhan, and M. Wasay Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients Neurology 53 1999 1151 1153
31. B. Colombo, B.F. Martinelli, P. Rossi, M. Rovaris, L. Maderna, and M. Filippi MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue J Neurol 247 2000 506 509
32. F. Cantor Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis PMR 2 2010 399 405
33. N. Téllez, J. Alonso, J. Rio, M. Tintoré, C. Nos, and X. Montalban The basal ganglia: a substrate for fatigue in multiple sclerosis Neuroradiology 50 2008 17 23
34. G. Niepel, C.R. Tench, P.S. Morgan, N. Evangelou, D.P. Auer, and C.S. Constantinescu Deep gray matter and fatigue in MS: a T1 relaxation time study J Neurol 253 2006 896 902
35. G. Riccitelli, M.A. Rocca, C. Forn, B. Colombo, G. Comi, and M. Filippi Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue AJNR Am J Neuroradiol 32 2011 874 879
36. O. Yaldizli, S. Glassl, D. Sturm, A. Papadopoulou, A. Gass, and B. Tettenborn Fatigue and progression of corpus callosum atrophy in multiple sclerosis J Neurol 258 2011 2199 2205
37. G. Tedeschi, D. Dinacci, L. Lavorgna, A. Prinster, G. Savettieri, and A. Quattrone Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability J Neurol Sci 263 2007 15 19
38. C. Pellicano, A. Gallo, X. Li, V.N. Lkonomidou, I.E. Evangelou, and O. JM Relationship of cortical atrophy to fatigue in patients with multiple sclerosis Arch Neurol 67 2010 447 453
39. R.A. Marrie, E. Fisher, D.M. Miller, J.C. Lee, and R.A. Rudick Association of fatigue and brain atrophy in multiple sclerosis J Neurol Sci 228 2005 161 166
40. M. Pardini, L. Bonzano, G.L. Mancardi, and L. Roccatagliata Frontal networks play a role in fatigue perception in multiple sclerosis Behav Neurosci 24 2010 329 336
41. M. Maes, I. Mihalyova, and M. De Ruyter Decreased dehydroepiandrosterone sulphate but normal insulin like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS Neuro Endocrinol Lett 26 2005 487 492
42. A.J. Cleare The neuroendocrinology of chronic fatigue syndrome Endocr Rev 24 2003 236 252
43. M. Gottschalk, T. Kumpfel, P. Flachenecker, M. Uhr, C. Trenkwalder, and F. Holsboer Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis Arch Neurol 62 2005 277 280
44. N. Téllez, M. Comabella, E. Julia, J. Río, M. Tintoré, and L. Brieva Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone Mult Scler 12 2006 487 494
45. I. Huitinga, M. van der Cammen, L. Salm, Z. Erkut, A. van Dam, and F. Tilders IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis J Neuroimmunol 107 2000 8 20
46. F. Zellini, G. Niepel, C.R. Tench, and C.S. Constantinescu Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis Mult Scler 15 2009 1442 1449
47. L. Leocani, B. Colombo, G. Magnani, F. Martinelli-Boneschi, M. Cursi, and P R Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement - EEG evidence Neuroimage 13 2001 1186 1192
48. G.W. Thickbroom, P. Sacco, D.L. Faulkner, A.G. Kermode, and F.L. Mastaglia Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis J Neurol 255 2008 1001 1005
49. N.M. Benwell, F.L. Mastaglia, and G.W. Thickbroom Changes in the functional MR signal in motor and non-motor areas during intermittent fatiguing hand exercise Exp Brain Res 182 2007 93 97
50. N. De Stefano, S. Narayanan, G.S. Francis, R. Arnaoutelis, M.C. Tartaglia, and J.P. Antel Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability Arch Neurol 58 2001 65 70
51. A.M. Blamire, S. Cader, M. Lee, J. Palace, and P.M. Matthews Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy Magn Reson Med 58 2007 880 885
52. C. Tartaglia, S. Narayanan, S.J. Francis, A.C. Santos, N. De Stefano, and Y. Lapierre The relationship between diffuse axonal damage and fatigue in multiple sclerosis Arch Neurol 61 2004 201 207
53. S.B. Patten, C.A. Beck, J.V. Williams, C. Barbui, and L.M. Metz Major depression in multiple sclerosis: a population-based perspective Neurology 61 2003 1524 1527
54. D.C. Kroencke, S.G. Lynch, and D.R. Denney Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern Mult Scler 6 2000 131 136
55. D.C. Mohr, S.L. Hart, I. Fonareva, and E.S. Tasch Treatment of depression for patients with multiple sclerosis in neurology clinics Mult Scler 12 2006 204 208
56. D.M. Ehde, G.H. Kraft, L. Chwastiak, M.D. Sullivan, L.E. Gibbons, and C.H. Bombardier Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis Gen Hosp Psychiatry 30 2008 40 48
57. M.W. Koch, A. Glazwnborg, M. Uyttenboogaart, J. Mostert, and J. De Keyser Pharmacologic treatment of depression in multiple sclerosis Cochrane Database Syst Rev 2011 CD007295
58. D.C. Mohr, A.C. Boudewyn, D. Goodkin, A. Bostrom, and L. Epstein Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis J Consult Clin Psychol 69 2001 942 949
59. D.C. Mohr, S.L. Hart, L. Julian, J.L. Catledge, L. Honos-Webb, and L. Vella Telephone administered psychotherapy for depression Arch Gen Psychiatry 62 2005 1007 1014
60. R.E. Boeschoten, M.M. Nieuwenhuis, P. van Oppen, B.M. Uitdehaag, C.H. Polman, and E.H. Collette Feasibility and outcome of a web-based self-help intervention for depressive symptoms in patients with multiple sclerosis: a pilot study J Neurol Sci 315 2012 104 109
61. A.M. Bamer, K.L. Johnson, D.A. Amtmann, and G.H. Kraft Prevalence of sleep problems in individuals with multiple sclerosis Mult Scler 14 2008 1127 1130
62. N. Tachibana, R.S. Howard, N. Hirsch, D.H. Miller, I.F. Moseley, and D. Fish Sleep problems in multiple sclerosis Eur Neurol 34 1994 320 323
63. A.M. Bamer, K.L. Johnson, D.A. Amtmann, and G.H. Kraft Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis Clin Epidemiol 2010 99 106
64. L. Ferini-Strambi Sleep disorders in multiple sclerosis Handb Clin Neurol 99 2011 1139 1146
65. I.S. Lobentanz, S. Asenbaum, K. Vass, C. Sauter, G. Klösch, and H. Kollegger Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality Acta Neurol Scand 110 2004 6 13
66. H.P. Attarian, K.M. Brown, S.P. Duntley, J.D. Carter, and A.H. Cross The relationship of sleep disturbances and fatigue in multiple sclerosis Arch Neurol 61 2004 525 528
67. A.N. Vgontzas, E. Zoumakis, H.M. Lin, E.O. Bixler, G. Trakada, and G.P. Chrousos Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist J Clin Endocrinol Metab 89 2004 4409 4413
68. G. Niepel, R.H. Bibani, J. Vilisaar, R. Langley, C.M. Bradshaw, and E. Szabadi Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil Neuropharmacology 2012 10.1016/j.neuropharm [PMID 22766394]
69. T. Sakurai The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness Nat Rev Neurosci 8 2007 171 181
70. E. Mignot, G.J. Lammers, B. Ripley, M. Okun, S. Nevsimalova, and S. Overeem The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias Arch Neurol 59 2002 1553 1562
71. T. Kato, T. Kanbayashi, K. Yamamoto, T. Nakano, T. Shimizu, and T. Hashimoto Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions Intern Med 42 2003 743 745
72. Y. Oka, T. Kanbayashi, T. Mezaki, K. Iseki, J. Matsubayashi, and G. Murakami Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis J Neurol 251 2004 885 886
73. S. Knudsen, P.J. Jennum, K. Korsholm, S.P. Sheikh, S. Gammeltoft, and J.L. Frederiksen Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis Mult Scler 14 2008 734 738
74. C.S. Constantinescu, G. Niepel, M. Patterson, A. Judd, M. Braitch, and A.J. Fahey Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness J Neurol Sci 307 2011 127 131
75. E. Papuć, Z. Stelmasiak, P. Grieb, G. Pawe, and K. Rejdak CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients Neurosci Lett 474 2010 Apr 9 12
76. B.R. Stanton, F. Barnes, and E. Silber Sleep and fatigue in multiple sclerosis Mult Scler 12 2006 481 486
77. J. Iriarte, M.L. Subira, and P. Castro Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors Mult Scler 6 2000 124 130
78. L.M. Metz, S.B. Patten, C.J. Archibald, J.I. Bakker, C.J. Harris, and D.G. Patry The effect of immunomodulatory treatment on multiple sclerosis fatigue J Neurol Neurosurg Psychiatry 75 2004 1045 1047
79. S.R. Schwid, M.D. Petrie, R. Murray, J. Leitch, J. Bowen, and A. Alquist A randomised controlled study of the acute and chronic effects of cooling therapy for MS Neurology 60 2003 1955 1960
80. F. Patti, M.R. Ciancio, E. Reggio, R. Lopes, F. Palermo, and M. Cacopardo The impact of outpatient rehabilitation on quality of life in multiple sclerosis J Neurol 249 2002 1027 1033
81. F. Patti, M.R. Ciancio, M. Cacopardo, E. Reggio, T. Fiorilla, and F. Palermo Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients. A randomised control trial J Neurol 250 2003 861 866
82. R. McCullagh, A.P. Fitzgerald, R.P. Murphy, and G. Cooke Long term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: a pilot study Clin Rehabil 22 2008 206 214
83. R.W. Motl, E. McAuley, and E.M. Snook Physical activity and multiple sclerosis: a meta analysis Mult Scler 11 2005 459 463
84. T.R. Brown, and G.H. Kraft Exercise and rehabilitation for individuals with multiple sclerosis Phys Med Rehabil Clin N Am 16 2005 513 555
85. K. Van Kessel, R. Moss-Morris, E. Willoughby, T. Chalder, M.H. Johnson, and E. Robinson A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue Psychosom Med 70 2008 205 213
86. K.W. Rammohan, J.H. Rosenberg, D.J. Lynn, A.M. Blumenfeld, C.P. Pollak, and H.N. Nagaraja Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study J Neurol Neurosurg Psychiatry 72 2002 179 183
87. R. Lange, M. Volkmer, C. Heesen, and J. Liepert Modafinil effects in multiple sclerosis patients with fatigue J Neurol 256 2009 645 650
88. B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, and L. Rumbach Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study Neurology 64 2005 1139 1143
89. L.B. Krupp, P.K. Coyle, C. Doscher, A. Miller, A.H. Cross, and L. Jandorf Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo Neurology 45 1995 1956 1961
90. F. Ashtari, F. Fatehi, V. Shaygannejad, and A. Chitsaz Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis? Neurol Neurochir Pol 43 2009 428 432
91. S.A. Brod, G.D. Marshall, E.M. Henninger, S. Sriram, M. Khan, and J.S. Wolinsky Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis Neurology 46 1996 1633 1638
92. D. Blockmans, P.P. Philippe, B. Van Houdenhove, and H. Bobbaers Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 119 2006 167 [e23-e30]
93. Y. Harel, N. Appleboim, M. Lavie, and A. Achiron Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process J Neurol Sci 276 2009 38 40
94. Rimes KA, Wingrove J. Mindfulness-Based Cognitive Therapy for People with Chronic Fatigue Syndrome Still Experiencing Excessive Fatigue after Cognitive Behaviour Therapy: A Pilot Randomized Study. Clin Psychol Psychother in press Oct 9, http://dx.doi.org/10.1002/cpp. 793. [PMID 21983916].
95. M.L. Van der Lee, and B. Garssen Mindfulness-based cognitive therapy reduces chronic cancer-related fatigue: a treatment study Psychooncology 21 2012 264 272
96. P. Grossman, L. Kappos, H. Gensicke, M. D'Souza, D.C. Mohr, and I.K. Penner MS quality of life, depression, and fatigue improve after mindfulness training; a randomized child Neurology 75 2010 1141 1149
97. R.P. Di Fabio, J. Sodeberg, T. Choi, C.R. Hansen, and R.T. Schapiro Extended outpatient rehabilitation: its influence on symptom frequency, fatigue and functional status or persons with progressive multiple sclerosis Arch Phys Med Rehabil 79 1998 141 146
98. K. Foglio, E. Clini, D. Facchetti, M. Vitacca, S. Marangoni, and M. Bonomelli Respiratory muscle function and exercise capacity in multiple sclerosis Eur Respir J 7 1994 23 28